logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
Showing 1 - 20 of 29 Items
Showing 1 - 20 of 29 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (20)
  • CSV
  • BibTeX
  • EndNote
  • All Results (29)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Strengthening non-communicable disease care in all-hazards emergencies

Jobanputra K, Perone SA, Ansbro É, Baraiah S, Beran D,  et al.
2025-10-01 • Lancet Diabetes and Endocrinology
2025-10-01 • Lancet Diabetes and Endocrinology

People with non-communicable diseases (NCDs) are particularly vulnerable to health service disruptions resulting from&...

Conference Material
|
Poster

Adapting type 1 diabetes care to an acute conflict in Lebanon

Boulle P, Bast M, Hammad L, Hachem T
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Journal Article
|
Review
Journal Article
|
Research
Journal Article
|
Review
Journal Article
|
Commentary

Diabetes care in humanitarian settings

Conference Material
|
Poster
Journal Article
|
Research
Journal Article
|
Letter
Conference Material
|
Slide Presentation
Journal Article
|
Commentary
Conference Material
|
Abstract
Journal Article
|
Letter
Journal Article
|
Commentary
Journal Article
|
Research
Journal Article
|
Commentary
Journal Article
|
Research
Journal Article
|
Review
Journal Article
|
Review
Conference Material
|
Abstract

The status of care for youth with type 1 diabetes within and coming from humanitarian crises settings: a narrative review

James S, Jabakhanji SB, Mehta R, McCaffrey J, Mairghani M,  et al.
2025-01-14 • Conflict and Health
2025-01-14 • Conflict and Health

BACKGROUND

Humanitarian crises bring unique, and potentially growing challenges to people with type 1 diabetes (T1D). We aimed to determine, in youth with T1D (...

Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries

Safary E, Lepeska M, Beran D, Ewen M, Zhaparova A,  et al.
2024-08-26 • PLOS One
2024-08-26 • PLOS One

AIMS

Most glucose self-monitoring devices have been developed with high-income countries in mind. We developed a target product profile (TPP) for new glucose self-monitoring tec...

Using clinical vignettes to understand the complexity of diagnosing type 1 diabetes in Sub-Saharan Africa

Le Bec E, Kam M, Aebischer Perone S, Boulle P, Cikomola J,  et al.
2023-11-13 • Research and Reports in Tropical Medicine
2023-11-13 • Research and Reports in Tropical Medicine
Lack of awareness, access to insulin and diabetes care can result in high levels of morbidity and mortality for children with type 1 diabetes (T1DM) in sub-Saharan Africa (SSA). Improvem...
Kehlenbrink S, Jobanputra K, Reddy A, Boulle P, Gomber A,  et al.
2023-06-18 • Endocrinology and Metabolism Clinics of North America
2023-06-18 • Endocrinology and Metabolism Clinics of North America
Despite the increasing prevalence of diabetes in populations experiencing humanitarian crisis, along with evidence that people living with diabetes are at higher risk for poor outcomes i...

Evaluating task-sharing for non-communicable disease management in humanitarian settings: lessons learned from MSF’s model of care in Lebanon

Doumit M, Masri S, Beltran I, Incerti A, Ciglenecki I,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023

Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study

Ansbro É, Masri S, Prieto-Merino D, Willis R, Aoun Bahous S,  et al.
2023-01-25 • BMJ Open
2023-01-25 • BMJ Open
OBJECTIVES
This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prev...

Where conflict's medical consequences remain unchanged [letter]

Fernandez G, Boulle P
2013-03-16 • Lancet
2013-03-16 • Lancet

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022

Forced migration and foot care in people with diabetes - Author's reply

Kehlenbrink S, Boulle P
2020-02-01 • Lancet Diabetes and Endocrinology
2020-02-01 • Lancet Diabetes and Endocrinology

Hypertension management in MSF programmes in Jordan and Zimbabwe: opportunities for simplification and use of fixed-dose combination medications

Oza S, Harris P, Ansbro E, Perel P, Frieden M,  et al.
2020-05-20 • MSF Scientific Days International 2020
2020-05-20 • MSF Scientific Days International 2020
INTRODUCTION
Globally, hypertension is responsible for approximately half of all heart disease and stroke deaths. Over 75% of these deaths occur in low- and middle-income countries. ...

An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settings

Kehlenbrink S, Mahboob O, Al-Zubi S, Boulle P, Aebischer-Perone S,  et al.
2022-02-07 • Lancet Diabetes and Endocrinology
2022-02-07 • Lancet Diabetes and Endocrinology

Diabetes in humanitarian crises: the Boston Declaration

Kehlenbrink S, Jaacks LM, Perone SA, Ansbro É, Ashbourne E,  et al.
2019-08-01 • Lancet Diabetes and Endocrinology
2019-08-01 • Lancet Diabetes and Endocrinology

Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

Boulle P, Sibourd Baudry A, Ansbro É, Prieto Merino D, Saleh N,  et al.
2019-08-09 • Conflict and Health
2019-08-09 • Conflict and Health
We included 514 patients with ASCVD in the cross-sectional study, performed in 2017. Most (61.9%) were male and mean age was 60.4 years (95% CI, 59.6-61.3). Over half (58.8%) underwent r...

Care of Non-Communicable Diseases in Emergencies

Slama S, Kim HJ, Roglic G, Boulle P, Hering H,  et al.
2016-09-13 • Lancet
2016-09-13 • Lancet

Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care

Kaufmann B, Boulle P, Berthou F, Fournier M, Beran D,  et al.
2021-02-03 • PLOS One
2021-02-03 • PLOS One
Strict storage recommendations for insulin are difficult to follow in hot tropical regions and even more challenging in conflict and humanitarian emergency settings, adding an extra burd...

Operational considerations for the management of non-communicable diseases in humanitarian emergencies

Bausch FJ, Beran D, Hering H, Boulle P, Chappuis F,  et al.
2021-02-25 • Conflict and Health
2021-02-25 • Conflict and Health
Non-communicable diseases (NCD) represent an increasing global challenge with the majority of mortality occurring in low- and middle-income countries (LMICs). Concurrently, many humanita...

Challenges associated with providing diabetes care in humanitarian settings

Boulle P, Kehlenbrink S, Smith JS, Beran D, Jobanputra K
2019-08-01 • Lancet Diabetes and Endocrinology
2019-08-01 • Lancet Diabetes and Endocrinology
The humanitarian health landscape is gradually changing, partly as a result of the shift in global epidemiological trends and the rise of non-communicable diseases, including diabetes. H...

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...